Scafoglio C et al. even suggested that SGLT2 inhibitors may be useful for cancer therapy (152), as SGLT2 inhibitor was associated to increased tumor necrosis and hence induced tumor shrinkage (152). Here, SLC5A2 is linked to neoplasm.